Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by E Fund Management Hong Kong Co. Ltd.

E Fund Management Hong Kong Co. Ltd. lowered its holdings in Axon Enterprise, Inc. (NASDAQ:AXON) by 11.3% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 173 shares of the biotechnology company’s stock after selling 22 shares during the quarter. E Fund Management Hong Kong Co. Ltd.’s holdings in Axon Enterprise were worth $103,000 as of its most recent filing with the SEC.

Other institutional investors also recently made changes to their positions in the company. Groupama Asset Managment purchased a new position in shares of Axon Enterprise in the 3rd quarter valued at about $200,000. Massachusetts Financial Services Co. MA purchased a new position in Axon Enterprise in the third quarter valued at about $120,553,000. International Assets Investment Management LLC acquired a new stake in shares of Axon Enterprise during the 3rd quarter valued at approximately $871,860,000. Westfield Capital Management Co. LP boosted its stake in shares of Axon Enterprise by 12.2% during the 3rd quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock worth $469,661,000 after acquiring an additional 127,769 shares in the last quarter. Finally, Assenagon Asset Management S.A. grew its holdings in shares of Axon Enterprise by 328.7% in the 4th quarter. Assenagon Asset Management S.A. now owns 145,299 shares of the biotechnology company’s stock worth $86,354,000 after acquiring an additional 111,405 shares during the period. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of analysts have commented on the company. The Goldman Sachs Group boosted their target price on Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a research report on Wednesday, October 23rd. Northland Securities increased their price objective on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research note on Monday, November 11th. Morgan Stanley upgraded shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and lifted their target price for the stock from $500.00 to $700.00 in a research report on Tuesday, December 3rd. Robert W. Baird increased their price target on shares of Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research report on Friday, December 6th. Finally, JMP Securities lifted their price objective on Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a research report on Thursday, October 31st. One research analyst has rated the stock with a hold rating and fourteen have given a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $504.92.

Insider Transactions at Axon Enterprise

In related news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total value of $271,831.50. Following the transaction, the director now directly owns 6,929 shares of the company’s stock, valued at approximately $4,185,601.03. This trade represents a 6.10 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Julie A. Cullivan sold 1,261 shares of Axon Enterprise stock in a transaction on Wednesday, December 4th. The shares were sold at an average price of $682.06, for a total value of $860,077.66. Following the completion of the transaction, the director now owns 2,392 shares in the company, valued at $1,631,487.52. The trade was a 34.52 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 50,545 shares of company stock worth $30,721,337 in the last three months. Company insiders own 6.10% of the company’s stock.

Axon Enterprise Stock Performance

NASDAQ AXON opened at $610.32 on Monday. The business’s 50-day moving average price is $617.65 and its 200 day moving average price is $472.00. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a twelve month low of $247.04 and a twelve month high of $698.67. The company has a market capitalization of $46.54 billion, a PE ratio of 157.71, a price-to-earnings-growth ratio of 6.09 and a beta of 1.04.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.